Literature DB >> 18155600

Oral undifferentiated high-grade pleomorphic sarcoma: report of a case.

Edson Alfredo1, Joubert Magalhães de Pádua, Eduardo Luis Vicentini, Melissa Andreia Marchesan, Raphael Carlos Comelli Lia, Danyel Elias da Cruz Perez, Yara Teresinha Corrêa Silva-Sousa.   

Abstract

The current World Health Organization classification considers the existence of an undifferentiated unclassifiable category of pleomorphic sarcomas, defined as a group of pleomorphic high-grade sarcomas. Undifferentiated high-grade pleomorphic sarcoma represents about 5% of all soft tissue sarcomas in adults and occurs more commonly in the extremities. In the oral cavity, undifferentiated pleomorphic sarcoma is extremely rare. We report a case of undifferentiated high-grade pleomorphic sarcoma located in the floor of the mouth in a man 56 years old. Microscopically, spindle-shaped cells with accented pleomorphism arranged in a storiform pattern, several bizarre giant cells, and frequent atypical mitoses were observed. The tumor cells were positive only for vimentin, with focal positivity for CD68. The patient was treated by surgery and postoperative radiation therapy, and after 25 months, no recurrence was observed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18155600     DOI: 10.1016/j.tripleo.2007.07.023

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  3 in total

1.  [Bleeding tumor of the auricle].

Authors:  M F Meyer; I Wedemeyer; D Beutner
Journal:  HNO       Date:  2013-10       Impact factor: 1.284

Review 2.  NF1 diagnosis criteria and associated sarcomatous tumor review of the literature and case report.

Authors:  Márcia Gaiger de Oliveira; Sabrina Pozatti Moure; Paulo Sérgio Batista; Anna Cecília Moraes Chaves; Pantelis V Rados; Manoel Sant'Ana Filho
Journal:  Oral Maxillofac Surg       Date:  2008-12

3.  Pleomorphic Sarcoma of the Oral Cavity: A Rare Case Entity.

Authors:  Sharada T Rajan; S Elengkumaran; Malathi Narasimhan; C Ravindran
Journal:  J Pharm Bioallied Sci       Date:  2021-11-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.